---
layout: post
title: The Gruggable Genome 
categories: 
share: true
comments: true
tag: [ ]
---

![](http://i.imgur.com/q4i43rm.png)

# The Druggable Genome: Evaluation of Drug Targets in Clinical Trials Suggests Major Shifts in Molecular Class and Indication

- Definition 
    - Druggable genome - susceptible to pharmacological interaction - involved in pathological mechanisms leading to disease
- [Drugs@FDA](https://www.accessdata.fda.gov/scripts/cder/drugsatfda/)

![](http://i.imgur.com/Cs3YBqf.png)

- [Centerwatch.com]

![](http://i.imgur.com/cWlmI39.png)

- protein kinase inhibitors : type I and II (pho 안됐을때 conformation inhibition안하는 경우)
- GPCR 
    - Rhodopsin
    - Secretin
    - Frizzled GPCR

![](http://i.imgur.com/FHQbfst.png)

## Indication

**Antineoplastic Drug Trials**

**Antidiabetic**

**Alzheimer - prevention of tau aggregation - exebryl-1, tideglusib (GSK3)**

**Appetite Regulation**

![](http://i.imgur.com/QgDxjba.png)

## Conclusion
- 555 unique genes encoding drug targets + 475 potentially nobel genome-encoded
